{"id":92,"date":"2019-07-04T03:10:43","date_gmt":"2019-07-04T03:10:43","guid":{"rendered":"http:\/\/wickedsister.evit.com.au\/?p=92"},"modified":"2019-07-04T03:10:43","modified_gmt":"2019-07-04T03:10:43","slug":"new-theory","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2019\/07\/04\/new-theory\/","title":{"rendered":"New &#8211; Theory"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">What\u2019s next in remyelination therapy?<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Remyelination substances currently under observation include the following (see <a href=\"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458518800827\"><em>Multiple Sclerosis Journal<\/em><\/a> for details):<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2019\/01\/Potential-remyelination-theories-under-investigation-2019-for-BNS.png\" alt=\"\" class=\"wp-image-57714\"\/><\/figure>\n\n\n\n<p class=\"has-background has-pale-cyan-blue-background-color\">New imaging technologies are under development to measure remyelination efficacy, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.mayfieldclinic.com\/PE-fMRI_DTI.HTM\">diffusion tensor imaging<\/a> (DTI)<\/li><li>magnetized transfer imaging (MTI)<\/li><li><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mrm.25198\">myelin water fraction imaging<\/a> (MWF)<\/li><li>positron emission tomography (PET)<\/li><\/ul>\n\n\n\n<p>The authors of \u201c<a href=\"https:\/\/www.omicsonline.org\/open-access\/remyelination-in-multiple-sclerosis-how-close-are-we-2155-9562-5-192.php?aid=24044\">Remyelination in Multiple Sclerosis \u2013 How Close are We?<\/a>\u201d in the&nbsp;<em><a href=\"https:\/\/www.omicsonline.org\/neurology-neurophysiology.php\">Journal of Neurology &amp; Neurophysiology<\/a>&nbsp;<\/em>assert that:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201cIf we can provide our MS patients with drugs promoting \nremyelination, we will be changing the natural history of the disease. \nThat is why it makes sense to think about this, as a much-needed \ntherapeutic strategy.\u201d<\/p><\/blockquote>\n\n\n\n<p>Remyelination\n therapy is not a cure, but can bring hope and maybe even a reversal of \nsymptoms for many who are severely disabled by MS. <\/p>\n\n\n\n<p><em>Does the prospect of remyelination therapy intrigue you? What \nquestions do you have about this novel approach? Post your replies in \nthe comments below or at the original \u201cNew MS Therapy Company to Focus \non Rejuvenating Coating That Protects Nerve Cells\u201d <a href=\"https:\/\/multiplesclerosisnewstoday.com\/forums\/forums\/topic\/new-ms-therapy-company-pipeline-to-focus-on-rejuvenating-coating-that-projects-nerve-cells\/\">forum<\/a> entry.<\/em><\/p>\n\n\n\n<p>***<\/p>\n\n\n\n<p><em>Note: <\/em><em><a href=\"http:\/\/multiplesclerosisnewstoday.com\/\">Multiple Sclerosis News Today<\/a><\/em><em>\n is strictly a news and information website about the disease. It does \nnot provide medical advice, diagnosis, or treatment. This content is not\n intended to be a substitute for professional medical advice, diagnosis,\n or treatment. Always seek the advice of your physician or other \nqualified health provider with any questions you may have regarding a \nmedical condition. Never disregard professional medical advice or delay \nin seeking it because of something you have read on this website. The \nopinions expressed in this column are not those of <\/em><em><a href=\"http:\/\/multiplesclerosisnewstoday.com\/\">Multiple Sclerosis News Today<\/a><\/em><em> or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What\u2019s next in remyelination therapy? Remyelination substances currently under observation include the following (see Multiple Sclerosis Journal for details): New imaging technologies are under development to measure remyelination efficacy, including: diffusion tensor imaging (DTI) magnetized transfer imaging (MTI) myelin water fraction imaging (MWF) positron emission tomography (PET) The authors of \u201cRemyelination in Multiple Sclerosis \u2013&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-92","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/92","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=92"}],"version-history":[{"count":1,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/92\/revisions"}],"predecessor-version":[{"id":93,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/92\/revisions\/93"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=92"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=92"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=92"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}